Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Investors Business Daily
Thu, 10/19/23 - 10:12 am
Intellia
CRISPR
gene editing
transthyretin amyloidosis with cardiomyopathy
VedaBio Launches with $40+ Million Toward a CRISPR Molecular Detection Platform
Genetic Engineering News
Tue, 10/17/23 - 11:47 am
VedaBio
CRISPR
molecular detection
A decade later, biotech’s CRISPR revolution is still going strong
BioPharma Dive
Thu, 10/12/23 - 05:14 pm
CRISPR
gene editing
biotech
AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
Best Stocks
Tue, 09/26/23 - 10:12 pm
AbbVie
Caribou Biosciences
CRISPR
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Thu, 09/14/23 - 10:56 pm
Tango Therapeutics
CRISPR
gene editing
clinical trials
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results
Clinical Trials Arena
Thu, 08/3/23 - 06:28 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
beta thalassemia
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes
Wed, 07/26/23 - 06:22 pm
Scribe Therapeutics
CRISPR
gene editing
Benjamin Oakes
CRISPR on the Cusp: The Promise and the Pain Points
BioSpace
Mon, 07/10/23 - 09:27 pm
Intellia Therapeutics
HAE
NTLA-2002
CRISPR
Patients attack-free a year after receiving Intellia's hereditary angioedema CRISPR med
Fierce Biotech
Sun, 06/11/23 - 11:07 pm
Intellia Therapeutics
HAE
hereditary angiodema
CRISPR
NTLA-2002
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
Fierce Biotech
Wed, 06/7/23 - 09:40 pm
BIO 2023
Caribou Biosciences
lymphoma
CRISPR
cell therapy
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
Fierce Biotech
Tue, 05/16/23 - 12:01 pm
Scribe Therapeutics
Eli Lilly
CRISPR
Prevail Therapeutics
gene therapy
biobucks
Jennifer Doudna
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
BioPharma Dive
Thu, 04/13/23 - 10:04 am
Function Oncology
CRISPR
diagnostics
funding
cancer
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Medtech Dive
Wed, 04/12/23 - 10:05 pm
Function Oncology
funding
CRISPR
diagnostics
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Tue, 03/28/23 - 11:46 am
Vertex Pharmaceuticals
diabetes
CRISPR
gene editing
CRISPR Therapeutics
Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Gene Editing
Investors Business Daily
Fri, 03/3/23 - 11:46 am
Intellia Therapeutics
CRISPR
FDA
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Fri, 02/24/23 - 09:03 am
Novartis
sickle cell disease
Intellia Therapeutics
CRISPR
gene editing
Vertex Teases Launch of Landmark CRISPR Therapy
BioSpace
Thu, 02/9/23 - 10:45 am
Vertex Pharmaceuticals
exa-cel
sickle cell disease
CRISPR
EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval
Fierce Biotech
Thu, 01/26/23 - 10:53 am
Vertex Pharmaceuticals
CRISPR Therapeutics
EMA
CRISPR
sickle cell disease
exa-cel
Here Are the Top Five Biotech Trends for 2023
NASDAQ
Mon, 12/19/22 - 11:23 am
biotech
personalized medicine
bioprinting
tissue engineering
orphan drugs
drug discovery
gene editing
CRISPR
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »